Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer.
Dan Li,Yulan Zhao,Changxing Liu,Xiaona Chen,Yanting Qi,Yue Jiang,Chao Zou,Xiaolong Zhang,Shunying Liu,Xuejing Wang,Dan Zhao,Qiang Sun,Zhenbing Zeng,Andreas Dress,Marie C. Lin,Hsiang-Fu Kung,Hallgeir Rui,Ling-Zhi Liu,Feng Mao,Bing-Hua Jiang,Lihui Lai
DOI: https://doi.org/10.1158/1078-0432.ccr-10-1800
IF: 13.801
2011-01-01
Clinical Cancer Research
Abstract:Abstract Purpose: To investigate expression, regulation, potential role and targets of miR-195 and miR-497 in breast cancer. Experimental Design: The expression patterns of miR-195 and miR-497 were initially examined in breast cancer tissues and cell lines by Northern blotting and quantitative real-time PCR. Combined bisulfite restriction analysis and bisulfite sequencing were carried out to study the DNA methylation status of miR-195 and miR-497 genes. Breast cancer cells stably expressing miR-195 and miR-497 were established to study their role and targets. Finally, normal, fibroadenoma and breast cancer tissues were employed to analyze the correlation between miR-195/497 levels and malignant stages of breast tumor tissues. Results: MiR-195 and miR-497 were significantly downregulated in breast cancer. The methylation state of CpG islands upstream of the miR-195/497 gene was found to be responsible for the downregulation of both miRNAs. Forced expression of miR-195 or miR-497 suppressed breast cancer cell proliferation and invasion. Raf-1 and Ccnd1 were identified as novel direct targets of miR-195 and miR-497. miR-195/497 expression levels in clinical specimens were found to be correlated inversely with malignancy of breast cancer. Conclusions: Our data imply that both miR-195 and miR-497 play important inhibitory roles in breast cancer malignancy and may be the potential therapeutic and diagnostic targets. Clin Cancer Res; 17(7); 1722–30. ©2011 AACR.